<title>Nektar Therapeutics (NKTR) News & Commentary

DJIA

15,132.62

-185.61

-1.21%

NASDAQ

3,447.42

-34.76

-1.00%

S&P 500

1,631.53

-20.28

-1.23%

6/19/2013 by Nasdaq

Chronic pain patients didn't "like" Nektar's pain management drug as much as oxycodone; and that's A-OK with Nektar!

6/19/2013 by DailyFinance

6/19/2013 by Benzinga

6/19/2013 by Nasdaq

6/19/2013 by Benzinga

Don't just ask, "How much inventory?" Ask, "What kind?"

6/19/2013 by DailyFinance

6/13/2013 by TheStreet

Market-lagging returns could be written in this 2-star stock.

6/12/2013 by DailyFinance

6/5/2013 by Zacks

6/3/2013 by Benzinga